Does polypharmacy increase the risk of premature death in older adults?
Polypharmacy is associated with a significantly increased mortality risk among older adults, highlighting the need to evaluate medication appropriateness.
A considerable proportion of older adults in Denmark were exposed to polypharmacy dependent on health status, socio-economic status, and societal factors. The associated three- to four-fold mortality risk indicate a need for further exploration of the appropriateness of polypharmacy among older adults.
Pallesen et al. (Wed,) studied this question.